This leads to reductions in the levels of inflammatory factors related to the development of pulmonary fibrosis, such as α-SMA, CTGF, and type III collagen, to alleviate pulmonary fibrosis [32–35]. This evidence concerns the gene CCN2 and pulmonary fibrosis.